CCOc1ccc(/N=N/C2C(=O)N(C(=O)CC(=O)Nc3ccccc3OC)N=C2C)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?